Mesenchymal Stem Cell Therapy Modulates the Inflammatory Response in Experimental Traumatic Brain Injury

Figure 3

Chemokine profile in serum in TBI acute and chronic phase. Serum from mice submitted to the TBI protocol was used to investigate for cytokines content. Mice were transplanted (MSC treated) or not (injury not treated) with MSC immediately after the injury and blood was collected after 24 hours (acute phase) (a) or 30 days (chronic phase) (b). (control 𝑛=3, injury no treatment 𝑛=6, MSC treated 𝑛=4). ^∗𝑃<.005, ^∗∗∗𝑃<.001.

(a)

(b)